Over site:

Domeinnaam - tafasitamab.be

Sitetitel - Titel van de site niet beschikbaar

Ga naar website - link geblokkeerd

Site Logo

IP-adres :

165.160.15.20 165.160.13.20

Domeinnaamservers :

dns1.cscdns.net dns2.cscdns.net

Alle records :

☆ tafasitamab.be. 3600 IN HINFO "RFC8482" ""

%
% The WHOIS service offered by DNS Belgium and the access to the records in the DNS Belgium
% WHOIS database are provided for information purposes only. It allows
% persons to check whether a specific domain name is still available or not
% and to obtain information related to the registration records of
% existing domain names.
%
% DNS Belgium cannot, under any circumstances, be held liable where the stored
% information would prove to be incomplete or inaccurate in any sense.
%
% By submitting a query you agree not to use the information made available
% to:
% - allow, enable or otherwise support the transmission of unsolicited,
% commercial advertising or other solicitations whether via email or otherwise;
% - target advertising in any possible way;
% - to cause nuisance in any possible way to the domain name holders by sending
% messages to them (whether by automated, electronic processes capable of
% enabling high volumes or other possible means).
%
% Without prejudice to the above, it is explicitly forbidden to extract, copy
% and/or use or re-utilise in any form and by any means (electronically or
% not) the whole or a quantitatively or qualitatively substantial part
% of the contents of the WHOIS database without prior and explicit permission
% by DNS Belgium, nor in any attempt thereof, to apply automated, electronic
% processes to DNS Belgium (or its systems).
%
% You agree that any reproduction and/or transmission of data for commercial
% purposes will always be considered as the extraction of a substantial
% part of the content of the WHOIS database.
%
% By submitting the query you agree to abide by this policy and accept that
% DNS Belgium can take measures to limit the use of its whois services in order to
% protect the privacy of its registrants or the integrity of the database.
%

Domain: tafasitamab.be
Status: NOT AVAILABLE
Registered: Tue Jun 9 2020

Registrant:
Not shown, please visit www.dnsbelgium.be for webbased whois.

Registrar Technical Contacts:
Organisation: CSC Corporate Domains, Inc.
Language: en
Phone: +1.3026365400


Registrar:
Name: CSC Corporate Domains, Inc.
Website: https://www.cscdigitalbrand.services/

Nameservers:
dns1.cscdns.net
dns2.cscdns.net

Keys:

Flags:
clientTransferProhibited

Please visit www.dnsbelgium.be for more info.

Brief facts about tafasitamab:

Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma. Tafasitamab may cause serious side effects including infusion related reactions, bone marrow suppression, infections, and harm to an unborn baby. The most common side effects of tafasitamab are low blood cell counts, fatigue, diarrhea, cough, fever, limb swelling, upper respiratory infection, and decreased appetite. Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody. Tafasitamab was approved for medical use in the United States in July 2020, and in the European Union in August 2021. The U.S. Food and Drug Administration considers it to be a first-in-class medication.

Monoclonal antibodies for tumors

Orphan drugs